A phase III randomised comparison of gemcitabine/carboplatin with cisplatin in small cell lung cancer.

Trial Profile

A phase III randomised comparison of gemcitabine/carboplatin with cisplatin in small cell lung cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Carboplatin; Cisplatin; Etoposide; Etoposide; Gemcitabine
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2009 Additional lead trial investigator Rudd R identified as reported by United Kingdom Clinical Research Network record.
    • 13 May 2009 New source identified and integrated (United Kingdom Clinical Research Network).
    • 16 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top